BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23439753)

  • 1. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
    Chang DK; Jamieson NB; Johns AL; Scarlett CJ; Pajic M; Chou A; Pinese M; Humphris JL; Jones MD; Toon C; Nagrial AM; Chantrill LA; Chin VT; Pinho AV; Rooman I; Cowley MJ; Wu J; Mead RS; Colvin EK; Samra JS; Corbo V; Bassi C; Falconi M; Lawlor RT; Crippa S; Sperandio N; Bersani S; Dickson EJ; Mohamed MA; Oien KA; Foulis AK; Musgrove EA; Sutherland RL; Kench JG; Carter CR; Gill AJ; Scarpa A; McKay CJ; Biankin AV
    J Clin Oncol; 2013 Apr; 31(10):1348-56. PubMed ID: 23439753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
    Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
    Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic subtype-based evaluation of recurrence and survival outcomes in patients with adenocarcinoma of the ampulla of Vater.
    Park SJ; Shin K; Hong TH; Lee SH; Kim IH; Kim Y; Lee M
    Sci Rep; 2023 Oct; 13(1):16547. PubMed ID: 37783755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histomolecular phenotypes of adenocarcinoma of the ampulla of vater: more evidence is required.
    Arroyo GF
    J Clin Oncol; 2013 Oct; 31(30):3842-3. PubMed ID: 24043729
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?
    Amptoulach S; Josefsson A; Kavantzas N; Kalaitzakis E
    Scand J Gastroenterol; 2011 Nov; 46(11):1401-3. PubMed ID: 21854095
    [No Abstract]   [Full Text] [Related]  

  • 10. Signet ring cell carcinoma of the ampulla of Vater: demonstration of a pancreatobiliary origin.
    Gheza F; Cervi E; Pulcini G; Villanacci V; Giulini SM; Schiavo-Lena M; Ferrari AB; Bassotti G
    Pancreas; 2011 Jul; 40(5):791-3. PubMed ID: 21673543
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
    Zhou H; Schaefer N; Wolff M; Fischer HP
    Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of carcinoma of the papilla of Vater.
    Fischer HP; Zhou H
    J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
    Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
    Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
    Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB
    J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
    Yun SP; Seo HI
    BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
    Leo JM; Kalloger SE; Peixoto RD; Gale NS; Webber DL; Owen DA; Renouf D; Schaeffer DF
    J Clin Pathol; 2016 May; 69(5):431-9. PubMed ID: 26500334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
    da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
    J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
    Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
    Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.